Board of Directors

Lawrence E. Posner

Lawrence E. Posner MD, MA (Econ.) has spent 25 years in the pharmaceutical industry and until recently held the title of Senior Vice President, Special Medical Liaison, for Bayer HealthCare, Pharmaceutical Division in West Haven Connecticut. He was formerly a member of the Scientific Advisory Board of Invesco Private Equity and serves as an advisor to Point Biomedical, San Carlos, California, on the development of novel, proprietary agents for ultrasound imaging. He is currently a partner at Vedanta Capital, a private equity firm in New York City, New York, specializing in direct healthcare investments.

Dr. Posner received his AB degree in Latin American Studies from Brandeis University in Waltham, Mass., and his MD from Case Western Reserve University, in Cleveland Ohio, where he was a member of the honor medical society, AOA. He completed his internal medicine training at the New York University Medical Center, and subspecialty training in medical oncology at the National Cancer Institute in Bethesda, Maryland, where he spent several years studying RNA tumor viruses in the Laboratory of Tumor Cell Biology under Dr. Robert Gallo. In 2005 he returned to school full time to complete a Master’s Degree in Economics at the University of Connecticut.

Dr. Posner began his career in the pharmaceutical industry in 1983 at the American Cyanamid Company’s Lederle Laboratories, and later moved to the Bayer Corporation’s U.S pharmaceutical headquarters in West Haven, Connecticut. There he held positions of increasing responsibility including Senior Vice President, U.S. Pharmaceutical Research and Development, SVP North American Product Development, and SVP and Head of Worldwide Regulatory Affairs for pharmaceutical products. He left Bayer in 2003 to become head of US R&D for Yamanouchi Pharma Ltd. of Tokyo, Japan, but left that position in 2004 following the merger with Fujisawa, and the relocation of the Company’s offices to Chicago, Ill. In his roles in pharmaceutical R&D Dr. Posner has filed more than ten original US and foreign new drug applications and over 50 supplemental applications for new dosage forms and uses. He and his wife, Amy Newburger, a dermatologist, have two children and reside in Greenwich, Connecticut.